Puma Biotechnology (PBYI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 38,539 | 43,044 | 137,408 | 53,382 | N/A |
| Marketable Securities | 102,788 | 40,904 | N/A | N/A | N/A |
| Receivables | 1,760 | 9,813 | 10,612 | N/A | N/A |
| TOTAL | $149,379 | $96,396 | $148,972 | $53,663 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 2,157 | 1,684 | 1,479 | 682 | N/A |
| Other Non-Current Assets | 11,222 | 6,294 | 1,248 | 1,053 | 0 |
| TOTAL | $13,379 | $7,978 | $2,727 | $1,735 | $N/A |
| Total Assets | $162,758 | $104,374 | $151,699 | $55,398 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 14,997 | 10,692 | 482 | 87 | 0 |
| Accrued Expenses | 29,444 | 8,579 | 21,219 | 500 | N/A |
| TOTAL | $44,441 | $19,271 | $21,701 | $587 | $N/A |
| Non-Current Liabilities | |||||
| TOTAL | $1,269 | $1,116 | $1,089 | $439 | $N/A |
| Total Liabilities | $45,710 | $20,387 | $22,790 | $1,026 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 31,919 | 30,118 | 28,677 | 20,040 | 3,000 |
| Common Shares | 3 | 3 | 3 | 2 | 0 |
| Retained earnings | -281,216 | -139,251 | -84,592 | -10,240 | -7 |
| Other shareholders' equity | -930 | 3 | 0 | 0 | 0 |
| TOTAL | $117,048 | $83,987 | $128,909 | $54,372 | $N/A |
| Total Liabilities And Equity | $162,758 | $104,374 | $151,699 | $55,398 | $0 |